financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Maintains Buy Opinion On Shares Of Zions Bancorporation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Maintains Buy Opinion On Shares Of Zions Bancorporation
Apr 21, 2026 8:37 AM

11:25 AM EDT, 04/21/2026 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

After digesting Q1 earnings, we raise our 12-month target price by $2 to $82, 12.2x our 2027 EPS estimate, a premium to the peer average of 10.0x given solid balance sheet growth prospects. We increase our 2026 EPS estimate by $0.22 to $6.44 and raise 2027's by $0.19 to $6.74. Our 2026 and 2027 revenue projections are $3.5 billion and $3.7 billion, respectively. ZION has demonstrated strong market share gains in recent quarters, standing out as one of the few banks to achieve both loan and deposit growth for two consecutive quarters. While the company has been conservative with share buybacks, reducing shares outstanding by only 1% over three years, we anticipate more aggressive repurchases ahead. This shift is supported by three factors: credit concerns from 2025 have largely subsided, ZION maintains a robust capital position with a CET1 ratio of 11.5% that exceeds peer averages despite already strong credit metrics, and the regulatory environment is improving.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kkr & Co. Inc.
Research Alert: CFRA Keeps Buy Opinion On Shares Of Kkr & Co. Inc.
Sep 10, 2025
01:45 PM EDT, 09/10/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our target price by $11 to $165 using a forward P/E 24.6x our 2026 earnings estimate, just below the five-year historical average at 26.9x and near direct peers....
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Chewy, Inc.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Chewy, Inc.
Sep 10, 2025
01:50 AM EDT, 09/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We raise our 12-month target by $1 to $54, based on a blended valuation of 20x FY 27 (Jan.) EBITDA and 2.0x FY 27 EV/sales. We lift our FY 26...
Research Alert: CFRA Lowers Opinion On Shares Of Fedex Corporation To Sell From Hold
Research Alert: CFRA Lowers Opinion On Shares Of Fedex Corporation To Sell From Hold
Sep 11, 2025
03:00 PM EDT, 09/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target price by $7 to $219, 12.1x our FY 26 (May) EPS view and below FDX's three- and five-year forward average of 12.8x. We cut our...
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Sep 11, 2025
02:50 AM EDT, 09/11/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target price of USD61, implying 16.3x our 2025 EPADS, a discount to historical forward P/E of 25x-30x to reflect growing concerns about long-term competitive positioning, yet above...
Copyright 2023-2026 - www.financetom.com All Rights Reserved